BM230

· Suzhou Biomissile Pharmaceuticals Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BM230, covering 2026-01-29 to 2026-01-29. Get the full timeline:

Most recent: Clinical Trial Update: Study of BM230 in Patients With Advanced Solid Tumors [Phase 1]